pancrelipase
| Brand name | Pancreaze |
|---|---|
| Active ingredient | pancrelipase |
| Strength | 37,000USP UNITS; 97,300USP UNITS; 149,900USP UNITS |
| Dosage form | Capsule, Delayed Release |
| Route | Oral |
| Modality | Biologic |
| FDA approval | April 2021 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.